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Ischemic stroke is the third leading cause of death and the primary cause of 
disability in major industrialized countries. Although several promising drugs 
have been identified in preclinical studies, no neuroprotective molecule has been 
reported to show clinical efficacy for acute phase treatment of ischemic stroke. 
One reason for this is the complexity of ischemic stroke, as stroke represents a 
series of reactions among blood microvessel parenchymal cells, which lead to the 
injury of parenchymal cells. Ultimately, ischemic stroke is a vascular disorder 
that profoundly affects neuronal function. Therefore, preventing neuronal death 
per se may not be enough to prevent severe neuronal dysfunction. As a result, the 
neurovascular unit, which consists of neurons, astrocytes and microvascular 
endothelial cells, has been proposed as a new therapeutic target for stroke in 
recent years. 
    Peroxisome proliferator-activated receptor α (PPARα) is a 
ligand-activated transcriptional factor belonging to the nuclear receptor family. 
Previous researches indicate that PPARα is the regulator of lipids, fatty acids, 
and lipoprotein metabolism. Recently, it has been reported that PPARα is also 
present in brain regions like frontal cortex, striatum and hippocampus and is 
expressed in cells in the brain such as neurons, astrocytes and microvascular 
endothelial cells, which are the main cellular composition of neurovascular unit. 
Researches indicated that the infarct volume in PPARα knockout mice was larger 
after cerebral ischemia than that in wild-type mice which further suggests that 
PPARα may be directly involved in neural protection after cerebral 
ischemia.However the features of PPARα expression in brain has not been fully 
elucidated, and the effects of endogenous high-affinity agonist of PPARα oleoyl 
ethanolamine (OEA) and the synthetic agonist lipid-lowering agents, 















needs further study. 
Cerebral ischemia was induced by middle cerebral artery occlusion(MCAO) 
in mice for 90 min and then reperfusion. First immunohistochemistry and 
immunofluorescence double labeling method were used to observe the 
expression of PPARα in brain at different time points after cerebral ischemia and 
reperfusion. Second, the neuroprotective effects and mechanisms of OEA and 
Fen on acute cerebral ischemia model were observed.Drugs were intragastrically 
administered at the same time of reperfusion and 2 h after reperfusion 
respectively. The neurological deficit score，infarct volume and brain edema 
degree were determined 24 h after reperfusion. The disruption of blood-brain 
barrier（BBB）was evaluated by the extravasations of Evans Blue (EB). The 
contents of maiondialdehyde (MDA) and the activity of superoxide dismutase 
(SOD) in the brain tissue homogenate were measured by the thiobarbituric acid 
(TBA) method and the xanthine oxidase luminescence method respectively.The 
results indicate that PPARα expression in cerebral ischemia and damage the 
central area of the vascular endothelial cells, weak expression in neurons and 
glial cells. PPARα agonist OEA（40mg/kg）and Fen (80 mg/kg) can reduce 
infarct volume, attenuated brain edema degree, decreased the extravasations of 
EB .All these results indicates that OEA and Fen have protective effect against 
acute focal cerebral ischemia reperfusion injury in mice.In particular, the BBB 
damage after cerebral ischemia has a protective effect. OEA and Fen can reduced 
the content of MDA, increased activity of SOD in brain tissue 
significantly.Therefore, attenuated the lipid peroxidation in brain tissues .PPARα 
antagonist MK886 against protective effect of OEA and Fen on cerebral 
ischemic injury, suggesting that OEA and Fen may reduce lipid peroxidation 
injury, protection of BBB. 
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1.1 BBB 与急性脑缺血再灌注后 NVU 损伤 
1.1.1 NVU 的组成 






















NVU 由神经元和BBB 构成。BBB 由血管内皮细胞、星形胶质细胞、周细
胞和胞外间隙组成。BBB 渗透性的改变直接影响神经系统内环境的稳定。内环
境的稳定是保证各个组分之间及与神经元之间的信号联系正常进行的前提条件。
BBB 各组分对于维持整体渗透性的完整均起到重要作用[6, 7]。 
（1）紧密连接  紧密连接存在于相邻血管内皮细胞之间，主要由跨膜蛋白
Claudins）、闭锁蛋白(occludin) 、紧密连接蛋白(zonulacccludens，ZO) 和连接










（3）周细胞  周细胞对维持BBB 的完整性具有重要作用，其缺损会导致内
皮细胞肥大，产生病理性的血管形态改变等现象。近年来研究表明，周细胞还具
有多向分化的干细胞潜能，在神经组织的损伤和修复中起到重要作用。 
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